These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7101242)

  • 21. Platelet malondialdehyde in cardiovascular disease: effect of prosthetic heart valves and cardioactive drugs on production.
    Sullivan JM; Taylor JC; Samaha JK
    Thromb Haemost; 1980 Oct; 44(2):76-80. PubMed ID: 7455995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone.
    Pedersen AK; Jakobsen P; Kampmann JP; Hansen JM
    Clin Pharmacokinet; 1982; 7(1):42-56. PubMed ID: 7042172
    [No Abstract]   [Full Text] [Related]  

  • 23. [Summary of the clinical papers on sulfinpyrazone (Anturan) under discussion with a preview of the current study program].
    Fontanilles F
    Wien Med Wochenschr Suppl; 1980; 61():23-4. PubMed ID: 6930767
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of sulphinpyrazone and aspirin on gastrointestinal blood loss in man.
    Dawson A; Lavinski C; Parsons V; Weston MJ
    Thromb Res; 1978 May; 12(5):947-50. PubMed ID: 307835
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet survival time in severe chronic airway obstruction.
    Steele P; Ellis JH; Genton E
    Chest; 1975 Feb; 67(2 Suppl):46S-47S. PubMed ID: 1112110
    [No Abstract]   [Full Text] [Related]  

  • 26. A morphologic overview of the porcine bioprosthetic heart valve.
    Riddle JM; Stein PD; Magilligan DJ
    Henry Ford Hosp Med J; 1982; 30(3):139-45. PubMed ID: 7161129
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.
    Peerschke EI; Zucker MB
    Thromb Haemost; 1980 Feb; 43(1):58-60. PubMed ID: 7404479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic peptides in heart valve disease.
    Ray SG
    Heart; 2006 Sep; 92(9):1194-7. PubMed ID: 16251227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Circulating thrombocyte aggregates in the venous blood of patients with artificial heart valves].
    Popadić M; Rezaković D; Haracić M; Kurto J; Kamhi J
    Med Arh; 1982; 36(5-6):237-9. PubMed ID: 7183866
    [No Abstract]   [Full Text] [Related]  

  • 30. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation.
    Kasimir MT; Weigel G; Sharma J; Rieder E; Seebacher G; Wolner E; Simon P
    Thromb Haemost; 2005 Sep; 94(3):562-7. PubMed ID: 16268473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex difference in antithrombotic effect of sulphinpyrazone.
    Pay GF; Wallis RB; Zelaschi D; Burley DM; Dalton M; Giorgiades E; Ginsburg J
    Lancet; 1982 Feb; 1(8269):461. PubMed ID: 6121137
    [No Abstract]   [Full Text] [Related]  

  • 33. [Relation between oxygen saturation of right atrial blood and cardiac index].
    Xu J; Chen Q; Zhou J; Liu L; Long X
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):187. PubMed ID: 9868072
    [No Abstract]   [Full Text] [Related]  

  • 34. [Multicenter studies in the USA and Canada: thrombocyte function inhibitor in ischemic cerebrovascular diseases].
    Blombäck M; Mettinger KL
    Lakartidningen; 1980 Jan; 77(5):320-2. PubMed ID: 7366288
    [No Abstract]   [Full Text] [Related]  

  • 35. [Molecular mechanisms and indicators of thrombogenesis after heart valve replacement].
    Scharf RE; Giers G
    Z Kardiol; 1998; 87 Suppl 4():7-19. PubMed ID: 9857462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of fibrinogen receptors on platelets of uremic patients is correlated with the content of GPIIb and plasma level of creatinine.
    Walkowiak B; Pawlowska Z; Michalak E; Cierniewski CS
    Thromb Haemost; 1994 Feb; 71(2):164-8. PubMed ID: 8191392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The endothelium, platelets, and brain ischemia.
    Caplan LR; Fisher M
    Rev Neurol Dis; 2007; 4(3):113-21. PubMed ID: 17943063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of thrombosis with antiplatelet drugs.
    Kahn SB
    Am Fam Physician; 1980 May; 21(5):166-8. PubMed ID: 7377074
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A platelet-derived factor chemotactic for rabbit arterial smooth muscle cells in culture.
    Ihnatowycz IO; Winocour PD; Moore S
    Artery; 1981; 9(4):316-27. PubMed ID: 7316781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.